• recombinant
  • We have previously shown that within tumors, recombinant interleukin-2 (rIL-2, aldesleukin) consistently activates tumor-associated macrophages and upregulates IFN-stimulated genes while inducing minimal migration, activation, or proliferation of T cells. (aacrjournals.org)
  • response
  • However, distinct signatures specific to response could be observed in responding lesions pretreatment that were amplified following rIL-2 administration. (aacrjournals.org)
  • By administering HD IL-2 followed by ipilimumab, or vice versa, we aim to assess whether the one-year survival is improved over historical controls, and to observe whether one sequence has an advantage over the other regarding practical administration and complete response rate," added Dr. Patel. (nestlehealthscience.com)
  • health
  • Some of the "Schedule F Recommended" entries may have been added or will shortly be added to the PDL by Health Canada, but either way these entries will continue to be listed in Schedule I of the NDS. (napra.ca)
  • For more information on the Prescription Drug List, please consult the Health Canada website . (napra.ca)